Patent · US Active

Compositions and methods for modulating hemostasis

US8329168B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 15, 2006
Grant dateDec 11, 2012
Priority date—
Expiry dateNov 26, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/21005
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Novel thrombin/prothrombin protease/zymogen variants which have anticoagulation activity and methods of use thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.